• Zinc, Serum
  • Ataxia telangiectasia
  • Human T-Cell Lymphotropic Virus (HTLV) I/II Antibody Screen
  • Cystatin C, Serum
  • Hereditary Breast Cancer Gene Mutation Panel, NGS (BreastNext®)
  • Solid Tumor Gene Mutation Panel, NGS (Oncotype MAP™, Guardant360® CDx, Guardant Reveal™, PGDx elio™, Northstar Select®, oncoReveal™, LiquidHALLMARK®, PredicineATLAS™, GENESEEQPRIME™, Plasma Complete™)
  • Human T-Cell Lymphotropic Virus (HTLV) I/II Antibody Confirmation
  • Phosphorus (Phosphate), Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
Medical Test

ICD10
Access to OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection is restricted.
Loading...